MIG
BMY icon

Mariner Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Mariner Investment Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-20,000
Closed -$3K – 202
2015
Q2 		$3K Buy
+20,000
New +$1.32M ﹤0.01% 207
2014
Q3 		– Sell
-10,000
Closed -$25K – 253
2014
Q2 		$25K Buy
+10,000
New +$493K ﹤0.01% 223

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mariner Investment Group's BMY Position: Q2 2016 in Review

Mariner Investment Group sold out of Bristol-Myers Squibb (BMY) in Q2 2016, closing a stake of 83,700 shares — an estimated $5.35M sold.

Mariner Investment Group first reported a position in BMY in Q2 2015 and held it in 4 quarters. The position peaked at $5.35M in Q1 2016. 1,577 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

  • Mariner Investment Group reported no remaining Bristol-Myers Squibb position as of Q2 2016 after selling out during the quarter.
  • Mariner Investment Group sold 83,700 Bristol-Myers Squibb shares in Q2 2016, an estimated $5.35M.
  • Mariner Investment Group first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 4 quarters.
  • Mariner Investment Group's Bristol-Myers Squibb position peaked at $5.35M in Q1 2016.
  • 1,577 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.